RPS6KB2 and breast carcinoma: In one example, the knockdown of S6K2 led to cell death in breast cancer cells, whereas the knockdown of S6K1 led to the activation of other pathways and ultimately to the inhibition of apoptosis, which corroborates the distinct roles of the underlying signaling networks [9].